J. Invest. Dermatol. 2019
A TP63 mutation causes prominent alopecia with mild ectodermal dysplasia.
Publish at 19.11.2019
The Imagine’s genomics core facility was created in 2008 to provide high-throughput genotyping, sequencing and gene expression services to the Necker research community on a fee-for-service basis. Experimental design and the, analysis and interpretation of results are performed on an interactive basis with investigators and the bioinformatics facility (Imagine Foundation/Paris Descartes University).
The genomic platform is equipped with :
The core facility provides :
Proposed applications :
responsable
Ingénieure d'étude
Assistant Ingénieur
Assistant Ingénieur
Assistante ingénieure
Assistante ingénieure
J. Invest. Dermatol. 2019
A TP63 mutation causes prominent alopecia with mild ectodermal dysplasia.
J. Clin. Invest. 2019
Human C-terminal CUBN variants associate with chronic proteinuria and normal ...